Clinical Trial Update: Stool Transplant in Pediatric Patients With Recurring C. Difficile Infection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating stool transplant for pediatric patients with recurring Clostridioides difficile infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: MemorialCare Health System | Conditions: Clostridium Difficile Colitis | Phase 2 | Status: COMPLETED